Use of Biomarkers in the Management of Heart Failure
- 11 March 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (9) , 1231-1233
- https://doi.org/10.1161/01.cir.0000057608.97285.20
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)Circulation, 2003
- Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failureThe American Journal of Medicine, 2002
- Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failureJournal of the American College of Cardiology, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Randomised study of effect of ibopamine on survival in patients with advanced severe heart failureThe Lancet, 1997
- Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunctionThe American Journal of Cardiology, 1995